Ranibizumab for choroidal neovascularization following atrophic involution of adult-onset foveomacular vitelliform dystrophy.

Ranibizumab for choroidal neovascularization following atrophic involution of adult-onset foveomacular vitelliform dystrophy.

Purpose: We report a case of adult-onset foveomacular vitelliform dystrophy (AOFVD) complicated with atrophic involution and subsequent choroidal neovascularization (CNV) and treated with intravitreal ranibizumab. Design: Case Report Methods: A 71-year-old woman diagnosed with AOFVD experienced...

Full description

Bibliographic Details
Main Author: Sebastian Martinez-Castillo
Format: Article
Language:English
Published: Pan-American Association of Ophthalmology 2013-08-01
Series:Vision Pan-America
Subjects:
Adult-Onset Foveomacular Vitelliform Dystrophy
Retinal Atrophy
Choroidal Neovascularisation
Ranibizumab
Online Access:http://journals.sfu.ca/paao/index.php/journal/article/view/90

Internet

http://journals.sfu.ca/paao/index.php/journal/article/view/90

Similar Items